Rating: 640 points*
*amount mentions of word 'www.entremed.com' on the other websites

Welcome! :: EntreMed, Inc.

Description: EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing the next generation of multi-mechanism oncology and anti-inflammatory drugs that target disease cells directly and the blood vessels that nourish them. EntreMed is focused on developing drugs that are safe and convenient, and provide the potential for improved patient outcomes. Panzem (2-methoxyestradiol or 2ME2), the Company’s lead drug candidate, is currently in clinical trials for cancer, as well as in preclinical develop

Most popular searches: wwwentremed.com, biotech, www.entremd.com, www.entremed.ocm, www.enremed.com, ww.entremed.com, tissue factor pathway, www.entreemd.com, panzem, ww.entremed.com, 2me2, entremed, www.entremde.com, hypoxia-inducible factor 1a, hif-1a, hypoxia-inducible factor 1a, www.etnremed.com, oncology, www.entremed.co, www.entrmed.com, par-2, www.entemed.com, www.entremedcom, enmd 0996, proteinase activated receptor, www.entermed.com, enmd, hif-1a, therapeutic pathways, cell cycle regulation, bioscience, www.entreed.com, www.entremed, small molecule therapeutics, www.etremed.com, www.entrmeed.com, www.entreme.dcom, hif, tissue factor pathway inhibitors, www.netremed.com, www.ntremed.com, www.entremed.cm, proteinase activated receptor-2, www.entremed.com, ww.wentremed.com, www.entremed.om, wwwe.ntremed.com, www.entremed.cmo, www.entreme.com, hypoxia-inducible factor 1 alpha, wwwentremed.com, 2-methoxyestradiol, www.entremedc.om, hif-1 alpha, tfpi, www.enrtemed.com